🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine if the addition of apalutamide to...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2015-11-27
Trial ID
NCT02489318
Treatments Being Tested
Italian multicenter study, will enroll \~566 pts with oligometastatic hormo...
Status
Recruiting
Location
European Institute of Oncology
Start Date
2023-03-01
Trial ID
NCT05649943
Treatments Being Tested
The optimal treatment for HRPC patients has not yet been established. Recen...
Status
Terminated
Location
Netherlands Cancer Institute
Start Date
2016-09
Trial ID
NCT03066154
The purpose of this phase 3B trial was to see how well a new trial drug (de...
Status
Completed
Location
Alabama Research Center
Start Date
2009-04
Trial ID
NCT00833248
Treatments Being Tested
Researchers are seeking better ways to treat men who have non-metastatic ca...
Status
Completed
Location
Many Locations
Start Date
2021-11-30
Trial ID
NCT05171387
Treatments Being Tested
RATIONALE: Androgens can cause the growth of prostate cancer cells. Androge...
Status
Active Not Recruiting
Location
University of South Alabama Mitchell Cancer Institute
Start Date
2011-07
Trial ID
NCT01368588
To evaluate the efficacy and safety of rezvilutamide in combination with an...
Status
Recruiting
Location
Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University
Start Date
2023-09-07
Trial ID
NCT06305832
Treatments Being Tested
Single-arm, single site, open label study of the effects of parenteral test...
Status
Completed
Location
Sibley Memorial Hospital
Start Date
2014-08-25
Trial ID
NCT02090114
Treatments Being Tested
The objective of this study was to compare the efficacy and safety of the c...
Status
Completed
Location
Site JP00024
Start Date
2016-11-02
Trial ID
NCT02918968
Treatments Being Tested
This is a Phase II, multi-center, placebo-controlled randomized controlled ...
Status
Withdrawn
Location
CHU de Québec - Université Laval
Start Date
2023-11-07
Trial ID
NCT06018116
Treatments Being Tested